Zhixiang Chen – Trademark Portfolio

Entity Type: 01

Zhixiang Chen holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AMZLADY and CILUPBAH. The owner is based in Shenzhen.

110, No. 6 Zizhu Sixth Road, Futian District

Shenzhen 518040 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CILUPBAH
CILUPBAH
Registered 2025
AMZLADY
AMZLADY
Registered 2021

Trademark Classifications

Zhixiang Chen's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Zhixiang Chen have?

Zhixiang Chen has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Zhixiang Chen file in?

Zhixiang Chen files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Zhixiang Chen's most well-known trademarks?

Zhixiang Chen's registered trademark portfolio includes well-known marks such as AMZLADY and CILUPBAH. These are among 2 currently registered trademarks in the portfolio.

What is Zhixiang Chen's trademark registration success rate?

Zhixiang Chen has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.